Multi-Label Nonlinear Matrix Completion With Transductive Multi-Task Feature Selection for Joint MGMT and IDH1 Status Prediction of Patient With High-Grade Gliomas.
Ontology highlight
ABSTRACT: The O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase 1 (IDH1) mutation in high-grade gliomas (HGG) have proven to be the two important molecular indicators associated with better prognosis. Traditionally, the statuses of MGMT and IDH1 are obtained via surgical biopsy, which has limited their wider clinical implementation. Accurate presurgical prediction of their statuses based on preoperative multimodal neuroimaging is of great clinical value for a better treatment plan. Currently, the available data set associated with this study has several challenges, such as small sample size and complex, nonlinear (image) feature-to-(molecular) label relationship. To address these issues, we propose a novel multi-label nonlinear matrix completion (MNMC) m
SUBMITTER: Chen L
PROVIDER: S-EPMC6443241 | biostudies-literature | 2018 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA